T-Cell Prolymphocytic Leukemia — Trials

T-Cell Prolymphocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

24 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: Ascentage Pharma Group Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02512497	Romidepsin Maintenance After Allogeneic Stem Cell Transplantation	completed	Phase 1	23	Ohio State University Comprehensive Cancer CenterOTHER	1	Sep 19, 2025	clinicaltrials
NCT05225584	Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors	completed	Phase 1	56	Kymera Therapeutics, Inc.INDUSTRY	1	Mar 19, 2025	clinicaltrials